TCL Archive Conversation with The Cancer Letter: Is Republican Control Better Than Two-Party Stalemate? December 19, 2014
TCL Archive Former Group Chair Responds To Niederhuber: Change But Don’t Dissolve Cooperative Groups July 2, 2010
TCL Archive FDA Committee Okays Leuprolide NDA, But Recommends Against Mitoxantrne, Epirubicin April 5, 1985
TCL Archive ODAC votes 9-6 in favor of Clolar for pediatric acute lymphoblastic leukemia, but votes against Marqibo for non-Hodgkin’s lymphoma. December 10, 2004